FabRx Podcast

Episode 112: Automating Compounding Pharmacies with FabRx 3D Printing

Category: Blog,Influencer Interviews,podcast
blank blank May 03, 2026

What if your pharmacist could create your personalized medication on demand? An exact dose based on your age, biology, and preferences in tastes, aesthetics, and textures? That’s not a future scenario. It’s happening now with FabRx and a whole industry behind 3D printed pharmaceuticals. We have previously hosted several virtual conversations on this topic, but this year I finally had the opportunity to meet in person with one of the leaders in the space at UCL in London. In this episode of The Lattice, I sat down with Prof. Alvaro Goyanes in the birthplace of FabRx to catch up on what is happening with FabRx and the 3D printed pharmaceutical industry.

⚠️ Disclaimer:
This podcast is for educational and informational purposes only. The views expressed do not constitute engineering, medical, or financial advice. The technologies and procedures discussed may not be commercially available or suitable for every case. Always consult with a qualified professional.

About our Guest:

Professor Alvaro Goyanes

blank

Alvaro Goyanes is the co-founder and CEO of FABRX, the first company dedicated to developing 3D printing technology for the fabrication of personalized medicines and medical devices. He is also an Honorary Associate Professor at University College London- School of Pharmacy (UK) and an Associate Professor at the Faculty of Pharmacy, University of Santiago de Compostela (Spain). A pioneer in the field, Alvaro was among the first researchers to explore the potential of 3D printing for manufacturing oral dosage forms and medical devices. Recognized as a world expert in 3D-printed medicines, he has been listed among the World’s Most Highly Influential Researchers by Web of Science for six consecutive years since 2019. Alvaro holds a PhD in Pharmaceutics from the University of Santiago de Compostela and previously worked as a Registered Pharmacist for three years, giving him firsthand insight into the needs of community pharmacy.

TIMESTAMPS:

  • 00:00 — Welcome & intro: visiting FABRX at UCL London
  • 00:45 — Alvaro introduces himself and FABRX’s founding story
  • 02:06 — Latest news: clinical partnerships, hospitals, and the US expansion with Pete Pharma
  • 03:53 — How 3D printing upgrades compounding pharmacy — the Nespresso analogy
  • 05:30 — Quality control deep dive: balance, pressure sensor, camera, and AI
  • 07:37 — What’s included with every M3DIMAKER printer today
  • 07:47 — The breadth of drugs in research: HRT, hydrocortisol, cancer, and more
  • 08:30 — 3D printed hydroxyurea for pediatric sickle cell patients — the Montreal collaboration
  • 10:15 — How many patients has FABRX impacted so far?
  • 10:50 — UK Point-of-Care Manufacturing Regulation: what it means for distributed pharma
  • 12:15 — European Medicines Agency’s new Q&A document on 3D printing
  • 13:18 — The first FDA-approved 3D printed medicine (Aprecia)
  • 13:34 — Printing medicines for outer space — conversations with NASA

Notes and links

👤 GUEST

🏢 FABRX

🤝 PARTNERSHIPS

📄 RESEARCH & PUBLICATIONS

📋 REGULATORY

📚 3DHEALS — ARTICLES & RESOURCES

🎓 3DHEALS ON-DEMAND COURSES

blank

Comments